Hence, our team speculated that the cancer promoter LDHC molecules were released from exosomes to the outside of cells to facilitate the proliferative ability and growth of oncocytes, and that LDHC might exert an effect on the micro-environment of cancer metabolic activity. The gene discussed is LDHC; the disease is cancer.